About
Technology
Issues
FAQ
Links
Official Page
EML4‐ALK
fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK
+
non‐small cell lung cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.